(Q46864787)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Geralyn M. Messerlian

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

11

Robert C Bast

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Richard G Moore

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Amy K Brown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

M Craig Miller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Steven Skates

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

W Jeffrey Allard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Margaret Steinhoff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Paul DiSilvestro

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

C O Granai

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

3 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

402-408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18061248%20AND%20SRC:MED&resulttype=core&format=json

A new method of estimating United States and state-level cancer incidence counts for the current calendar year

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

The surgical management of women with ovarian cancer in the south west of England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Who should operate on patients with ovarian cancer? An evidence-based review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Osteopontin as a potential diagnostic biomarker for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Serum and tissue measurements of CA72-4 in ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Inhibins/activins as diagnostic markers for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Secretion of activin A in recurrent epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Novel screening strategies for early ovarian cancer by transabdominal ultrasonography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Ovarian cancer screening in asymptomatic postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.017